Pleomorphic

Pleomorphic means "having many shapes." In pathology, it describes cells that vary widely in size, shape, and appearance under the microscope, often a sign of an aggressive cancer. When applied to mesothelioma, it identifies a particularly poorly differentiated subtype where tumor cells look chaotic and irregular.

Origin

From the Greek pleion ("more") and morphe ("form"), the term entered scientific use in the 19th century to describe organisms and cells that take on multiple forms. Pathologists adopted it to characterize tumors whose cells lack uniformity, a hallmark of high-grade malignancy.

Significance in Asbestos Context

Pleomorphic mesothelioma is a recognized variant, most often classified as a subtype of epithelioid or sarcomatoid mesothelioma, and it generally carries a worse prognosis than the more common epithelioid form. If your pathology report uses the word "pleomorphic," it can affect treatment decisions, including whether surgery is offered, and it may influence eligibility for certain clinical trials. Because pleomorphic features can be confused with other cancers like lung carcinoma or sarcoma, accurate diagnosis usually requires immunohistochemistry and review by a mesothelioma-experienced pathologist. For legal claims, the exact subtype on the pathology report matters: it documents the severity of disease and supports the medical narrative that experts and treating physicians will rely on.

Example Sentence

The pathology report described the tumor as a pleomorphic variant of epithelioid mesothelioma, which prompted the oncologist to recommend systemic therapy rather than surgery.

Related Terms

Epithelioid Mesothelioma, Sarcomatoid Mesothelioma, Biphasic Mesothelioma, Immunohistochemistry, Histology, Differentiation

Notes

• Ask your oncologist whether your pathology report identifies a pleomorphic component and how that affects your treatment options and prognosis.
• Request a second opinion on the pathology slides from a center experienced with mesothelioma (such as an NCI-designated cancer center or a mesothelioma program); subtype calls can change with expert review.
• Preserve copies of the original pathology report, immunohistochemistry results, and any second-opinion reports. These documents are central to both medical decisions and any legal claim.
• If a pleomorphic diagnosis is made, ask whether tissue should be preserved for molecular testing or possible clinical trial enrollment.